Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds RSS Feed PharmiWeb Candidate Blog RSS Feed PharmiWeb Client Blog


Press Release

Global Ophthalmic Drug & Devices Market Growth of 7% CAGR by 2022 - Analysis, Technologies & Forecasts Report 2016-2022 - Key Vendors: Abbott Labs, Bayer, Merck - Research and Markets

Research and Markets
Posted on: 16 Sep 16

Research and Markets has announced the addition of the "Global Ophthalmic Drug & Devices Market, Opportunity, Analysis, Market Shares And Forecast 2016 - 2022" report to their offering.

The market for global ophthalmic drugs market was valued around $17,290 million in the year 2015 and is projected to grow with a CAGR of around 7% during the forecast period of 2016-2022.

The global ophthalmic drugs market is set to display a stable growth during 2016-2022 period which is attributed to various influencing factors such as the mounting prevalence of eye diseases and eye related disorders such as glaucoma and cataract, along with the expanding pool of geriatric population across the globe who are more prone to age-related macular degeneration, it is characterized by loss of central vision.

Also, the various pending regulatory approvals to new ophthalmic drugs that are expected to get approval by the end of the forecast period, along with the heightened sense of awareness among people, especially in the emerging economies are creating significant opportunities for the market. Moreover, rapid technological advancements and innovations resulting in combining drugs and device therapy, and various implants are being used to treat a wide array of eye related disorder.

Some of these implants such as ODTx, MicroPump, transscleral and encapsulated cell therapy are expected to provide further boost to the ophthalmic drugs market. This, along with the growing healthcare expenditure by various economies across the globe are expected to propel the growth of the market.

Companies Mentioned:

  • Abbot Laboratories
  • Akorn
  • Allergan Inc.
  • Bayer
  • Cipla Pharmaceuticals
  • Eye Gate Pharmaceuticals
  • Eyemed
  • Glaxosmithkline
  • Johnson And Johnson
  • Lpath
  • Merck & Co.
  • Novagali Pharma S.A.
  • Novartis Ag
  • Pfizer Inc.
  • Regeneron
  • Roche Holding Ag
  • Santen Pharmaceutical Co. Ltd.
  • Senju
  • Sun Pharmaceuticals
  • Valeant

Report Structure:

1. Introduction

2. Market Overview

3. Market Determinants

4. Market Segmentation

5. Geographical Analysis

6. Company Profiles

For more information about this report visit

Related Topics: Optical

View source version on

Business Wire

Last updated on: 16/09/2016

Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.